888-776-0942 from 8 AM - 10 PM ET
DUBLIN , April 1, 2022 /PRNewswire/ -- The "Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient's body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth.
The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited. Key Questions Answered in This Report:
Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Empty Capsules Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 Gelatin Capsule 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Non-gelatin Capsule 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Raw Material 7.1 Pig Meat 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Bovine Meat 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Bone 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Hydroxypropyl Methylcellulose (HPMC) 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Functionality 8.1 Immediate-release Capsules 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Sustained-release Capsules 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Delayed-release Capsules 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Therapeutic Application 9.1 Antibiotic and Antibacterial Drugs 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Vitamins and Dietary Supplements 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Antacid and Antiflatulent Preparations 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Cardiovascular Therapy Drugs 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by End User 10.1 Pharmaceutical Industry 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Nutraceutical Industry 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Cosmetics Industry 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Others 10.4.1 Market Trends 10.4.2 Market Forecast 11 Market Breakup by Region 12 SWOT Analysis 13 Value Chain Analysis 14 Porters Five Forces Analysis 15 Price Analysis 16 Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 ACG Associated Capsules Pvt. Ltd. 16.3.1.1 Company Overview 16.3.1.2 Product Portfolio 16.3.2 Bright Pharma Caps Inc. 16.3.2.1 Company Overview 16.3.2.2 Product Portfolio 16.3.3 CapsCanada Corporation 16.3.3.1 Company Overview 16.3.3.2 Product Portfolio 16.3.4 HealthCaps India Limited 16.3.4.1 Company Overview 16.3.4.2 Product Portfolio 16.3.5 Lonza Group AG 16.3.5.1 Company Overview 16.3.5.2 Product Portfolio 16.3.5.3 Financials 16.3.5.4 SWOT Analysis 16.3.6 Medicaps Limited 16.3.6.1 Company Overview 16.3.6.2 Product Portfolio 16.3.6.3 Financials 16.3.7 Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation) 16.3.7.1 Company Overview 16.3.7.2 Product Portfolio 16.3.8 Nectar Lifesciences Limited 16.3.8.1 Company Overview 16.3.8.2 Product Portfolio 16.3.8.3 Financials 16.3.9 Roxlor LLC 16.3.9.1 Company Overview 16.3.9.2 Product Portfolio 16.3.10 Shanxi Guangsheng Medicinal Capsules Co. Ltd 16.3.10.1 Company Overview 16.3.10.2 Product Portfolio 16.3.11 Snail Pharma Industry Co. Ltd 16.3.11.1 Company Overview 16.3.11.2 Product Portfolio 16.3.12 Suheung Co. Ltd 16.3.12.1 Company Overview 16.3.12.2 Product Portfolio 16.3.13 Sunil Healthcare Limited 16.3.13.1 Company Overview 16.3.13.2 Product Portfolio 16.3.13.3 Financials For more information about this report visit https://www.researchandmarkets.com/r/6873cw
Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
More news releases in similar topics
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET